3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
234
Squamous Cell Carcinoma of Head and Neck
168
Head and Neck Neoplasms
141
Lung Neoplasms
110
Esophageal Neoplasms
109
Nasopharyngeal Carcinoma
104
Uterine Cervical Neoplasms
101
Stomach Neoplasms
88
Esophageal Squamous Cell Carcinoma
86
Breast Neoplasms
69
Urinary Bladder Neoplasms
66
Small Cell Lung Carcinoma
58
Pancreatic Neoplasms
56
Neoplasms
55
Carcinoma, Squamous Cell
55
Cholangiocarcinoma
53
Ovarian Neoplasms
45
Neoplasm Metastasis
44
Oropharyngeal Neoplasms
43
Biliary Tract Neoplasms
41
Adenocarcinoma Of Esophagus
35
Recurrence
29
Mesothelioma, Malignant
28
Triple Negative Breast Neoplasms
25
Laryngeal Neoplasms
25
Nasopharyngeal Neoplasms
24
Lymphoma
24
Gallbladder Neoplasms
24
Sarcoma
21
Carcinoma
21
Interventions
Doxorubicin
8
Cyclophosphamide
8
Vincristine
7
Prednisone
7
Etoposide
6
Brentuximab Vedotin
4
prednylidene
3
etoposide phosphate
3
Bortezomib
3
pembrolizumab
2
deltacortene
2
Vorinostat
2
Prednisolone
2
Ifosfamide
2
tazemetostat
1
romidepsin
1
pirarubicin
1
duvelisib
1
Salvia hispanica seed extract
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Nivolumab
1
Methylprednisolone
1
Methotrexate
1
Melphalan
1
Lenalidomide
1
Lactones
1
Gemcitabine
1
Everolimus
1
Diet, Gluten-Free
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Enteropathy-Associated T-Cell Lymphoma
×
Cisplatin
×
Clear all
NCT01719835
2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2
Unknown
87 enrolled